-
Moderna rally loses steam over COVID-19 vaccine worries
-
Inovio Pharmaceuticals (INO) PT Lowered to $11 at Roth Capital
-
Roth Capital Downgrades Inovio Pharmaceuticals (INO) to Neutral on Valuation
-
After-Hours Movers 01/27: (XLRN) (SURF) (INO) Higher; (EROS) (FFIV) (RMBS) Lower (more...)
-
Pre-Open 12/19: (PRTK) (RAD) (TIVO) Higher (NERV) (APOG) (XPER) Lower (more...)
-
After-Hours Movers 12/18: (AMPE) (NBEV) (MU) Higher; (NERV) (MLHR) (GDOT) Lower (more...)
-
Roth Capital Starts Inovio Pharmaceuticals (INO) at Buy
-
Pre-Open Stock Movers 03/21: (GIII) (PTE) (CAG) Higher; (BIIB) (LQDA) (GES) Lower (more...)
-
Streetinsider.com's Hot Lunchtime Reads 10/24: (ADRO) (AMTD) (TWTR) (INO)
-
Pre-Open Stock Movers 11/17: (CLDX) (BHI) (AGN) Higher; (DWA) (GSAT) (HAL) Lower (more...)
-
Morning Movers 07/07: (CALI) (APAC) (INO) (OCZ) (FEED) Higher; (LL) (AFFX) (FST) Lower
-
Roth Capital Starts Inovio Pharmaceuticals (INO) at Buy, $2 Price Target
-
Morning Movers 3/26: ABIO, CPWM, SMOD, VTIV, TUTR Higher; ATAC, FBC, APP, WSCI, MNTX Lower
-
Roth Capital Initiates Coverage on Inovio Biomedical (INO) with a Buy

